trifluoromethanesulfonic acid has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balachandran, C; Ignacimuthu, S; Parthasarathy, K; Perumal, PT; Praveen, C; Senthil kumar, P | 1 |
Cavanaugh, PG; Nicolson, GL | 1 |
2 other study(ies) available for trifluoromethanesulfonic acid and Lung Neoplasms
Article | Year |
---|---|
Cu(OTf)2 catalyzed three component reaction: efficient synthesis of spiro[indoline-3,4'-pyrano[3,2-b]pyran derivatives and their anticancer potency towards A549 human lung cancer cell lines.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Binding Sites; Catalysis; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Humans; Isatin; Lung Neoplasms; Mesylates; Molecular Conformation; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrans; Pyrones; Receptor Protein-Tyrosine Kinases; Spiro Compounds | 2013 |
Purification and characterization of a Mr approximately 66,000 lung-derived (paracrine) growth factor that preferentially stimulates the in vitro proliferation of lung-metastasizing tumor cells.
Topics: Adenocarcinoma; Animals; Cell Division; Cyanogen Bromide; Dithiothreitol; Lung Neoplasms; Mesylates; Molecular Weight; Rats; Swine; Temperature; Tissue Extracts; Tumor Cells, Cultured | 1990 |